Pompe Pregnancy Sub-Registry



Status:Recruiting
Conditions:Endocrine, Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:Any
Updated:4/21/2016
Start Date:November 2011
End Date:January 2030
Contact:Medical Information
Email:MedInfo@genzyme.com
Phone:800-745-4447

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Sub-Registry to Observe the Effect of Myozyme (Alglucosidase Alfa) Treatment on Pregnancy and Infant Growth in Women With Pompe Disease

The objective is to track pregnancy outcomes in women with Pompe Disease and to follow
infants born to women with Pompe Disease.

Study Design Time Perspective: Retrospective and Prospective

Inclusion Criteria:

- Enroll in or agree to enroll in Pompe Registry

- Be pregnant or have been pregnant with appropriate medical documentation

- Provide a signed Patient Information and Authorization Form to participate in the
sub-registry prior to any sub-registry related data collection is performed

Exclusion Criteria:

- No Exclusion Criteria
We found this trial at
1
site
Registry participation is worldwide and not limited to this facility; facilities not yet active may enroll upon identification of a patient.
Cambridge, Massachusetts 02142
?
mi
from
Cambridge, MA
Click here to add this to my saved trials